← All news
Markets

What Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Tell Us About Cannabidiol As Licensed Medicine?

1 source ·1 article ·Sep 1, 10:29 UTC Jazz Pharmaceuticals

Highlights The group's cannabidiol oral solution holds marketing authorisation for specific treatment-resistant epilepsy conditions. New clinical and real-world evidence has been presented at major neurology and epilepsy meetings. The medic…

Covered by 1 outlet

All coverage · 1 article